Aim of the study: During the last few years, the ‘neurotrophic model’ has received increasing interest not only as an etiologic hypothesis for psychiatric disorders, but also as an explicative paradigm of the mechanism of action of pharmacological treatments. In particular, it has been hypothesized that genetic differences related to factors involved in CNS neuroplasticity may in part explain individuals’ variation in ADs response. However, both animal and human studies have provided mixed and conflicting results so far, suggesting that the genetic effects related to neuroplastic factors may be moderated by other biological, environmental, and individual factors. The aim of the study is to preliminarily evaluate the interactive effect of Stressful Life Events (SLEs) and genetic variation within two genes involved in neuroplastic processes (BDNF and ST8SIA) on the early response to antidepressant treatment. Methods: The sample was composed of 114 patients affected by Mood or Anxiety disorders, enrolled for treatment with ADs, scoring 8 or more at the Hamilton Rating Scale for Depression score (HAMD), and having filled at the time of recruitment a modified version (selfreport) of the Brown & Harris Stressful Life Events and Difficulties Interview (SLEDS). This modified version allows for investigations into stressful life events (SLEs) at a young age (less than 15 years old), the year before illness onset, and the month preceding current episode. All the patients were evaluated at baseline and weekly thereafter until the fourth week by the Hamilton Rating Scale for Depression (HRSD). Subjects were genotyped for 3 single-nucleotide polymorphisms (SNPs) in BDNF and 5 in ST8SIA. Linkage disequilibrium among SNPs was calculated by Haploview software and haplotypes were obtained by the R-software. The GLM model was employed to test the effect of alleles and haplotypes, crossed with exposure to stress, on % response at follow-up. Results: SLEs did not impact significantly on early response to ADs. Alleles in two SNPs in BDNF (rs11030101 A-allele and rs11030104 G-allele) and alleles in two SNPs in ST8SIA2 (rs11853992-A allele and rs17522085-T) were associated with a slower response to ADs only if not exposed to onset SLEs, whilst they had a similar response to the carriers of the opposite variant if exposed to onset SLEs (allelic analysis: BDNF P< 0.00003; P< 0.00609: ST8SIA P< 0.04; P< 0.033). The BDNF haplotype analysis confirmed this trend (P< 0.00016). Discussion: According to our data, variants in BDNF and ST8SIA may slow down the early response to antidepressants in subjects not exposed to stressors at the illness onset, with a remarkable gene–environment interaction. This results are significant considering that environmental stress is thought to hamper response to AD [1] and the few studies that consider geneenvironment interaction in pharmacological trials usually report a worse response in subjects exposed to stress if they are carriers of specific risk variants (see for example [2]). Nevertheless, the interplay between stress, neuroplasticity, mental distress and pharmacological treatment is far from being clear and deserves further investigation by means of sophisticated methods of investigation.
Read full abstract